Gabriel C. Léger

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia

Marsel Mesulam, Alissa Wicklund, Nancy Johnson et al. · Annals of Neurology · 2008 · 519 citations · Full text

Medicine, Neurology, Neuroscience +17

Dopa decarboxylase activity of the living human brain.

Albert Gjedde, Jakob Reith, Suzan Dyve et al. · Proceedings of the National Academy of Sciences · 1991 · 171 citations

Life Sciences, Neurobiology, Neuroscience +15

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Adam M. Staffaroni, Melanie Quintana, Barbara Wendelberger et al. · Nature Medicine · 2022 · 138 citations · Full text

Medicine, Neurology, Neuroscience +16

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer et al. · The Lancet Neurology · 2021 · 117 citations

Medicine, Pharmacology, Pharmacotherapy +14

6-[ ¹⁸ F]fluoro-l-DOPA Metabolism in Living Human Brain: A Comparison of Six Analytical Methods

Hiroaki Hoshi, Hiroto Kuwabara, Gabriel C. Léger et al. · Journal of Cerebral Blood Flow & Metabolism · 1993 · 107 citations · Full text

Medicine, Neuroscience, Nuclear Medicine +17